81 – 90 of 121
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
- Contribution to journal › Article
-
Mark
Atherosclerosis: cell biology and lipoproteins.
- Contribution to journal › Article
-
Mark
Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation.
- Contribution to journal › Article
-
Mark
Mobilization of regulatory T cells in response to carotid injury does not influence subsequent neointima formation.
- Contribution to journal › Article
-
Mark
Soluble Urokinase Plasminogen Activator Receptor is Associated With Inflammation in the Vulnerable Human Atherosclerotic Plaque.
- Contribution to journal › Article
- 2011
-
Mark
Immunization with cationized BSA inhibits progression of disease in ApoBec-1/LDL receptor deficient mice with manifest atherosclerosis.
- Contribution to journal › Article
-
Mark
Genome-Wide Expression Profiling and Mutagenesis Studies Reveal that Lipopolysaccharide Responsiveness Appears To Be Absolutely Dependent on TLR4 and MD-2 Expression and Is Dependent upon Intermolecular Ionic Interactions
- Contribution to journal › Article
-
Mark
Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
- Contribution to journal › Article
-
Mark
Atherosclerosis: cell biology and lipoproteins.
- Contribution to journal › Article
-
Mark
Rip2 Deficiency Leads to Increased Atherosclerosis Despite Decreased Inflammation.
- Contribution to journal › Article
